ACCELERON PHARMA INC. - Daily - Technical analysis published on 12/02/2019 (GMT)
- Who voted?
- 257
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
ACCELERON PHARMA INC. Chart
Summary of the analysis
Trends
Court terme:
Strongly bullish
De fond:
Strongly bullish
Technical indicators
83%
0%
17%
My opinion
Bullish above 47.29 USD
My targets
53.85 USD (+8.26%)
58.47 USD (+17.55%)
My analysis
ACCELERON PHARMA INC. is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 47.29 USD. The next resistance located at 53.85 USD is the next bullish objective to be reached. A bullish break in this resistance would boost the bullish momentum. The bullish movement could then continue towards the next resistance located at 58.47 USD. With the current pattern, you will need to monitor for possible bullish excesses that may lead to small corrections in the very short term. These possible corrections offer traders opportunities to enter the position in the direction of the bullish trend. Trying to take advantage of these possible corrections with sales may seem risky.
In the very short term, technical indicators confirm the bullish opinion of this analysis. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
FORCE
0
10
8.4
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay.
Additional analysis
Quotes
ACCELERON PHARMA INC. rating 49.74 USD. On the day, this instrument gained +1.59% and was traded between 48.49 USD and 49.74 USD over the period. The price is currently at +2.58% from its lowest and 0% from its highest.48.49
49.74
49.74
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Technical
Technical analysis of ACCELERON PHARMA INC. in Daily shows a strongly overall bullish trend. 89.29% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, 15 technical indicators on 18 studied are currently positioned bullish. Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Resistance of channel is broken
Type : Bullish
Timeframe : Daily
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S3
S2
S1
R1
R2
Price
S3 | S2 | S1 | Price | R1 | R2 | |
---|---|---|---|---|---|---|
ProTrendLines | 40.27 | 43.25 | 47.29 | 49.74 | 53.85 | 58.47 |
Change (%) | -19.04% | -13.05% | -4.93% | - | +8.26% | +17.55% |
Change | -9.47 | -6.49 | -2.45 | - | +4.11 | +8.73 |
Level | Minor | Intermediate | Major | - | Minor | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 46.54 | 47.18 | 48.07 | 48.71 | 49.60 | 50.24 | 51.13 |
Camarilla | 48.54 | 48.68 | 48.82 | 48.96 | 49.10 | 49.24 | 49.38 |
Woodie | 46.67 | 47.24 | 48.20 | 48.77 | 49.73 | 50.30 | 51.26 |
Fibonacci | 47.18 | 47.76 | 48.13 | 48.71 | 49.29 | 49.66 | 50.24 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 41.21 | 42.92 | 45.94 | 47.64 | 50.67 | 52.37 | 55.39 |
Camarilla | 47.66 | 48.09 | 48.53 | 48.96 | 49.39 | 49.83 | 50.26 |
Woodie | 41.87 | 43.25 | 46.60 | 47.97 | 51.32 | 52.70 | 56.05 |
Fibonacci | 42.92 | 44.72 | 45.84 | 47.64 | 49.45 | 50.57 | 52.37 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 33.76 | 36.95 | 42.96 | 46.15 | 52.16 | 55.35 | 61.36 |
Camarilla | 46.43 | 47.27 | 48.12 | 48.96 | 49.80 | 50.65 | 51.49 |
Woodie | 35.16 | 37.66 | 44.36 | 46.86 | 53.56 | 56.06 | 62.76 |
Fibonacci | 36.95 | 40.47 | 42.64 | 46.15 | 49.67 | 51.84 | 55.35 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
RSI (14): | 67.58 | |
MACD (12,26,9): | 1.4500 | |
Directional Movement: | 19.29 | |
AROON (14): | 64.29 | |
DEMA (21): | 47.03 | |
Parabolic SAR (0,02-0,02-0,2): | 41.44 | |
Elder Ray (13): | 2.88 | |
Super Trend (3,10): | 43.89 | |
Zig ZAG (10): | 49.71 | |
VORTEX (21): | 1.1100 | |
Stochastique (14,3,5): | 98.09 | |
TEMA (21): | 48.09 | |
Williams %R (14): | -0.54 | |
Chande Momentum Oscillator (20): | 5.09 | |
Repulse (5,40,3): | 6.8000 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.2600 | |
Courbe Coppock: | 15.91 |
MA7: | 47.13 | |
MA20: | 44.80 | |
MA50: | 42.89 | |
MA100: | 43.40 | |
MAexp7: | 47.47 | |
MAexp20: | 45.39 | |
MAexp50: | 44.02 | |
MAexp100: | 43.46 | |
Price / MA7: | +5.54% | |
Price / MA20: | +11.03% | |
Price / MA50: | +15.97% | |
Price / MA100: | +14.61% | |
Price / MAexp7: | +4.78% | |
Price / MAexp20: | +9.58% | |
Price / MAexp50: | +12.99% | |
Price / MAexp100: | +14.45% |
News
Don"t forget to follow the news on ACCELERON PHARMA INC.. At the time of publication of this analysis, the latest news was as follows:
- Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy
- Acceleron Receives FDA Orphan Drug Designation for Sotatercept in Pulmonary Arterial Hypertension
- Acceleron Receives FDA Orphan Drug Designation for ACE-083 in Charcot-Marie-Tooth Disease
- Acceleron to Webcast Fourth Quarter and Full Year 2018 Operating and Financial Results on February 27, 2019
- Acceleron to Present at Two Upcoming Healthcare Investor Conferences
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis ACCELERON PHARMA INC. - Daily